AMD 3100 for Treatment of Myelokathexis
NCT01058993
·
clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
6
Enrollment
OTHER
Sponsor class
Conditions
Neutropenia
Interventions
DRUG:
AMD3100 or plerixafor
Sponsor
University of Washington